211 related articles for article (PubMed ID: 23934585)
1. Physical exercise is associated with less neurocognitive impairment among HIV-infected adults.
Dufour CA; Marquine MJ; Fazeli PL; Henry BL; Ellis RJ; Grant I; Moore DJ;
J Neurovirol; 2013 Oct; 19(5):410-7. PubMed ID: 23934585
[TBL] [Abstract][Full Text] [Related]
2. A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults.
Dufour CA; Marquine MJ; Fazeli PL; Umlauf A; Henry BL; Zlatar Z; Montoya JL; Ellis RJ; Grant I; Moore DJ;
AIDS Behav; 2018 May; 22(5):1562-1572. PubMed ID: 27990580
[TBL] [Abstract][Full Text] [Related]
3. HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis.
Walker KA; Brown GG
J Clin Exp Neuropsychol; 2018 May; 40(4):357-376. PubMed ID: 28689493
[TBL] [Abstract][Full Text] [Related]
4. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy.
Garvey LJ; Yerrakalva D; Winston A
AIDS Res Hum Retroviruses; 2009 Aug; 25(8):765-9. PubMed ID: 19678764
[TBL] [Abstract][Full Text] [Related]
5. The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.
Harrison JD; Dochney JA; Blazekovic S; Leone F; Metzger D; Frank I; Gross R; Hole A; Mounzer K; Siegel S; Schnoll RA; Ashare RL
J Neurovirol; 2017 Aug; 23(4):550-557. PubMed ID: 28429289
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
7. Cognitive disorders in HIV-infected patients: are they HIV-related?
Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
[TBL] [Abstract][Full Text] [Related]
8. Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease.
Fazeli PL; Marquine MJ; Dufour C; Henry BL; Montoya J; Gouaux B; Moore RC; Letendre SL; Woods SP; Grant I; Jeste DV; Moore DJ;
AIDS Behav; 2015 Aug; 19(8):1470-7. PubMed ID: 25731660
[TBL] [Abstract][Full Text] [Related]
9. Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir.
Robertson K; Maruff P; Ross LL; Wohl D; Small CB; Edelstein H; Shaefer MS
J Neurovirol; 2019 Feb; 25(1):22-31. PubMed ID: 30298202
[TBL] [Abstract][Full Text] [Related]
10. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort.
Moore DJ; Roediger MJ; Eberly LE; Blackstone K; Hale B; Weintrob A; Ganesan A; Agan BK; Letendre SL; Crum-Cianflone NF
PLoS One; 2012; 7(11):e47310. PubMed ID: 23144815
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
13. The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.
Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M
J Neurovirol; 2016 Feb; 22(1):56-65. PubMed ID: 26304840
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.
Cohen RA; Boland R; Paul R; Tashima KT; Schoenbaum EE; Celentano DD; Schuman P; Smith DK; Carpenter CC
AIDS; 2001 Feb; 15(3):341-5. PubMed ID: 11273214
[TBL] [Abstract][Full Text] [Related]
15. Better quality of life with neuropsychological improvement on HAART.
Parsons TD; Braaten AJ; Hall CD; Robertson KR
Health Qual Life Outcomes; 2006 Feb; 4():11. PubMed ID: 16504114
[TBL] [Abstract][Full Text] [Related]
16. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.
McCutchan JA; Marquie-Beck JA; Fitzsimons CA; Letendre SL; Ellis RJ; Heaton RK; Wolfson T; Rosario D; Alexander TJ; Marra C; Ances BM; Grant I;
Neurology; 2012 Feb; 78(7):485-92. PubMed ID: 22330412
[TBL] [Abstract][Full Text] [Related]
17. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.
Choi Y; Townend J; Vincent T; Zaidi I; Sarge-Njie R; Jaye A; Clifford DB
J Neurovirol; 2011 Apr; 17(2):166-75. PubMed ID: 21424866
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.
Cysique LA; Brew BJ
J Neurovirol; 2011 Apr; 17(2):176-83. PubMed ID: 21416169
[TBL] [Abstract][Full Text] [Related]
19. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
[TBL] [Abstract][Full Text] [Related]
20. Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.
Bharti AR; McCutchan A; Deutsch R; Smith DM; Ellis RJ; Cherner M; Woods SP; Heaton RK; Grant I; Letendre SL
Clin Infect Dis; 2016 Dec; 63(12):1655-1660. PubMed ID: 27794019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
